Read + Share
Amedeo Smart
Independent Medical Education
Pampusch MS, Abdelaal HM, Cartwright EK, Molden JS, et al. CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection. PLoS Pathog 2022;18:e1009831.PMID: 35130312
Email
LinkedIn
Facebook
Twitter
Privacy Policy